X-ray Structure-Based Chemoinformatic Analysis Identifies Promiscuous Ligands Binding to Proteins from Different Classes with Varying Shapes.
activity data
binding modes
complex X-ray structures
multitarget activity
promiscuity
protein classes
shape similarity
small molecules
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
27 May 2020
27 May 2020
Historique:
received:
30
04
2020
revised:
18
05
2020
accepted:
24
05
2020
entrez:
31
5
2020
pubmed:
31
5
2020
medline:
13
2
2021
Statut:
epublish
Résumé
(1) Background: Compounds with multitarget activity are of interest in basic research to explore molecular foundations of promiscuous binding and in drug discovery as agents eliciting polypharmacological effects. Our study has aimed to systematically identify compounds that form complexes with proteins from distinct classes and compare their bioactive conformations and molecular properties. (2) Methods: A large-scale computational investigation was carried out that combined the analysis of complex X-ray structures, ligand binding modes, compound activity data, and various molecular properties. (3) Results: A total of 515 ligands with multitarget activity were identified that included 70 organic compounds binding to proteins from different classes. These multiclass ligands (MCLs) were often flexible and surprisingly hydrophilic. Moreover, they displayed a wide spectrum of binding modes. In different target structure environments, binding shapes of MCLs were often similar, but also distinct. (4) Conclusions: Combined structural and activity data analysis identified compounds with activity against proteins with distinct structures and functions. MCLs were found to have greatly varying shape similarity when binding to different protein classes. Hence, there were no apparent canonical binding shapes indicating multitarget activity. Rather, conformational versatility characterized MCL binding.
Identifiants
pubmed: 32471121
pii: ijms21113782
doi: 10.3390/ijms21113782
pmc: PMC7312685
pii:
doi:
Substances chimiques
Ligands
0
Lipids
0
Proteins
0
Kanamycin
59-01-8
Indomethacin
XXE1CET956
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Déclaration de conflit d'intérêts
The authors declare no conflict of interest.
Références
Curr Opin Struct Biol. 2006 Feb;16(1):127-36
pubmed: 16442279
Future Sci OA. 2017 Mar 06;3(2):FSO179
pubmed: 28670471
Future Med Chem. 2014 Apr;6(5):485-7
pubmed: 24649950
Bioinformatics. 2013 Dec 15;29(24):3241-2
pubmed: 24064416
Nucleic Acids Res. 2014 Jan;42(Database issue):D285-91
pubmed: 24288376
Nat Chem Biol. 2008 Nov;4(11):682-90
pubmed: 18936753
J Med Chem. 2005 Jun 16;48(12):4111-9
pubmed: 15943484
Nucleic Acids Res. 2017 Jan 4;45(D1):D158-D169
pubmed: 27899622
J Med Chem. 2013 Nov 27;56(22):8955-71
pubmed: 23919353
Nucleic Acids Res. 2003 Jan 1;31(1):489-91
pubmed: 12520059
Nature. 2014 Sep 25;513(7519):481-3
pubmed: 25254460
ChemMedChem. 2016 Jun 20;11(12):1190-2
pubmed: 27061625
PLoS One. 2013 Jun 21;8(6):e65894
pubmed: 23805191
PLoS One. 2016 Apr 15;11(4):e0153873
pubmed: 27082988
Drug Discov Today. 2006 Jul;11(13-14):607-15
pubmed: 16793529
Nucleic Acids Res. 2016 Jan 4;44(D1):D1214-9
pubmed: 26467479
J Mol Biol. 2004 Jun 4;339(3):607-33
pubmed: 15147845
J Med Chem. 2019 Jan 24;62(2):420-444
pubmed: 30035545
Nat Genet. 2000 May;25(1):25-9
pubmed: 10802651
Sci Rep. 2017 Aug 31;7(1):10102
pubmed: 28860623
ACS Omega. 2018 Jan 31;3(1):106-111
pubmed: 30023769
Nucleic Acids Res. 2017 Jan 4;45(D1):D945-D954
pubmed: 27899562
ACS Omega. 2019 Jan 22;4(1):1729-1737
pubmed: 31459430
PLoS One. 2010 Aug 16;5(8):e12214
pubmed: 20808948